Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 26,010 shares at $1.80 ($47K) on 2017-12-01, disclosed to the SEC on 2017-12-05.
Open-market purchase of $47k ALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 5,215 | $9K | 20.1% |
| 2 | $1.81 | 7,300 | $13K | 28.3% |
| 3 | $1.78 | 13,495 | $24K | 51.5% |
| Total | $1.79 avg | 26,010 | $47K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |